Financials
Income statement
| Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|
| Total reported revenue | 30.8B | 37.9B | 39.2B | 43.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 12.7B | 13.3B | 12.7B | 12.9B |
| Other operating expenses | 7.4B | 10.4B | 19.4B | 18.1B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 9.5B | 14.1B | 7.0B | 12.5B |
| Tax provision | 3.0B | 4.3B | 1.1B | 3.4B |
| Net income | 6.5B | 9.8B | 5.8B | 9.0B |
| Basic EPS | — | — | — | 22.4 |
| Diluted EPS | — | — | — | 22.4 |
| Basic average shares | — | — | — | 65.4B |
| Diluted average shares | — | — | — | 65.4B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |